Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Jan 19, 2017 19.11 -0.31   
 A. Schulman SHLM Jan 19, 2017 32.50 -1.37   
 Aaon Inc AAON Jan 19, 2017 32.25 +0.16   
 Aastrom Biosciences ASTM Jan 19, 2017 2.77 0.00   
 Abaxis Inc ABAX Jan 19, 2017 48.48 -0.04   
 Abengoa S.A. ABGB Jan 19, 2017 1.02 0.00   
 Abeona Therapeutics Inc. ABEOW Jan 19, 2017 3.00 0.00   
 Abeona Therapeutics Inc. ABEO Jan 19, 2017 5.00 -1.96   
 Ability Inc. ABIL Jan 19, 2017 3.38 +1.20   
 Abiomed ABMD Jan 19, 2017 112.21 -0.94   
 Abraxas Petroleum Corp AXAS Jan 19, 2017 2.69 -0.74   
 AC Asia Ex Japan Smallcap MSCI Ishares AXJS Jan 19, 2017 52.38 0.00   
 AC Asia Information Tech MSCI Ishares AAIT Jan 19, 2017 30.53 0.00   
 AC Immune SA ACIU Jan 19, 2017 12.65 -2.54   
 Acacia Communications, Inc. ACIA Jan 19, 2017 63.29 +5.47   
 Acacia Research Corp ACTG Jan 19, 2017 5.80 -5.69   
 Acadia Healthcare Company Inc ACHC Jan 19, 2017 38.19 -2.08   
 Acadia Pharmaceuticals Inc ACAD Jan 19, 2017 31.43 -2.72   
 Acasti Pharma Inc ACST Jan 19, 2017 1.26 -1.56   
 Accelerate Diagnostics Inc AXDX Jan 19, 2017 21.35 -3.17   
 Acceleron Pharma Inc XLRN Jan 19, 2017 24.44 -1.09   
 Accelrys Inc ACCL Jan 19, 2017 12.51 0.00   
 Access National Corp ANCX Jan 19, 2017 27.65 -1.39   
 Accuray Incorporated ARAY Jan 19, 2017 5.30 -0.93   
 Acelrx Pharmaceuticals ACRX Jan 19, 2017 2.70 -1.82   
 Aceto Corp ACET Jan 19, 2017 19.65 -2.24   
 Achaogen, Inc. AKAO Jan 19, 2017 18.84 +5.96   
 Achillion Pharmaceuticals ACHN Jan 19, 2017 4.09 -1.45   
 Aci Worldwide ACIW Jan 19, 2017 18.88 +0.32   
 Aclaris Therapeutics, Inc. ACRS Jan 19, 2017 27.75 -0.89   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK